Executive functions and insight in OCD : a comparative study by Manarte, Lucas et al.
RESEARCH Open Access
Executive functions and insight in OCD: a
comparative study
Lucas Manarte1* , António R. Andrade2, Linete do Rosário1, Daniel Sampaio1, Maria Luísa Figueira1,
Pedro Morgado3 and Barbara J. Sahakian4
Abstract
Background: Around 25 to 30% of patients with obsessive-compulsive disorder (OCD) do not respond to
treatment. These patients have the longest duration of disease and the worst prognosis. Following years of research
on this topic, insight has emerged as a potential explanation for this therapeutic resistance. Therefore, it has
become important to characterize OCD patients with poor insight. Few studies have focused on the
neuropsychological and cognitive characteristics of these patients.
Methods: To help fill this gap, we divided 57 patients into two groups, one with good insight and the other with
poor insight, assessed their neuropsychological functions—through a Rey’s figure test, a California verbal learning
test, a Toulouse–Piéron test and a Wisconsin Card Sorting Test (WCST)—and compared the results with those of a
paired control group.
Results: The statistical analysis, with a significance level of 95%, revealed differences in the executive function tests,
and particularly in the WCST (p ≤ 0.001) and trail-making-test (TMT A/B) (p = 0.002).
Conclusions: These differences suggest that the neuropsychological profile of poor-insight patients is different
from their good-insight counterparts, emphasize the role played by the executive functions in insight and
highlights the need for more accurate neurocognitive research and treatment.
Keywords: Obsessive-compulsive disorder, Insight, Wisconsin card sorting Test, Verbal memory, Trail-making test,
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Background
Obsessive-compulsive disorder (OCD) affects 2% of
adults worldwide and 10% of the adult clinical popula-
tion [1]. Cognitive-behavioural psychotherapy is ineffect-
ive in 20% of cases and selective serotonin reuptake
inhibitors (SSRIs) in 40% [2], although other studies sug-
gest higher percentages for both treatments, around 40–
60% [3]. Three factors can account for these low success
rates: comorbidity, intensity of the symptoms and insight
[4], with a prevalence of the latter [5–10]. Around 15–
36% of OCD patients have poor insight [5, 11–16],
which makes insight one of the most promising topics
for future research in OCD [3, 17, 18].
Poor insight has been linked to many different factors:
lower education levels [9], earlier age of disease onset,
greater duration of disease [11, 15], chronic evolution
and OCD family history [13] were the most cited. It has
also been associated with more severe symptoms [5, 11,
12, 14] and a greater psychiatric comorbidity [9, 11–15].
The notion of insight has been the object of contro-
versy and is viewed since 1990 as a multidimensional
construct [19, 20]. On a psychopathological level, the
connection between a lower insight in OCD and
obsessive-compulsive symptoms has yet to be clarified
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[21]. Recent meta-analyses suggest that individuals with
OCD have poorer verbal memory/fluency and visuo-
spatial abilities/memory than healthy individuals and
fare worse across several executive domains, such as sus-
tained attention, processing speed and working memory
[22]. However, OCD is a heterogeneous disorder, and
these analyses do not specify which subgroup of OCD
patients best fits this neuropsychological profile.
Executive functions are subserved by a neural net-
work which includes regions of the frontal lobes [23,
24]. Executive functioning leads us to a set of func-
tions or cognitive skills that, as defined in the dic-
tionary of the International Neuropsychological
Society, are “necessary to perform complex behaviors
aimed at a certain objective” and determine our
“adaptive capacity to different demands and environ-
mental changes” [25]. These functions thus include a
variety of adaptive skills and processes that allow the
individual to “analyze what they want, how they
might get it (ie form a plan, based often on recollec-
tions of past experience), and then carry that plan
out”. Executive functions play an important and de-
termining role in the individual’s cognitive, emotional
and social regulation and, therefore, in the adoption
of an effective, creative and socially acceptable con-
duct [26]. Given its nature and its role, it is not sur-
prising that a commitment at this level can have a
devastating impact on the person’s life, both in terms
of the effectiveness of its daily functioning and in
terms of the relationships it establishes with others.
For this reason, it is important to have neuropsycho-
logical instruments to assess these functions. Execu-
tive functions include a wide range of cognitive
processes, such as strategic working memory, cogni-
tive flexibility, cognitive control of behaviour, plan-
ning and problem solving. Attention, the ability to
anticipate, the establishment of objectives, the sequen-
cing of activities, self-regulation and monitoring of
behaviors, initiative, abstraction and spontaneity.
Since the prefrontal cortex has been identified by
the specialized literature as the main neuroanatomical
substrate for executive functions [26], much scientific
knowledge has been produced in relation to the topic.
Nevertheless, there are debates about issues related to
the true nature of this construct, as well as the skills
that integrate them. In this sense, several models of
brain organization have been developed in order to
explain the complex nature of these functions [25].
The present study aims to clarify whether poor-insight
OCD patients have a different neuropsychological profile
than their good-insight counterparts. To do so, and re-
gardless of other clinical variables—such as age, sex,
education, OCD symptoms (Yale–Brown Obsessive-
Compulsive Scale, Y-BOCS), medication and insight
(Brown Assessment of Beliefs Scale, BABS)—different
aspects of neurocognition were analysed, namely: visual
and verbal memory (Rey’s figure test, California verbal
learning test, subjective memory questionnaire), visual
attention and task switching (trail-making test), atten-
tion, working memory, visual processing, abstract rea-
soning, and the ability to change problem-solving
strategies (Wisconsin Card Sorting Test), attention and
perception (Toulouse–Piéron test).
The neuropsychological performance of OCD patients
has drawn increasing attention [27, 28]. Since OCD pa-
tients were historically viewed as having average or
above average intelligence [29], their performance defi-
cits were not fully understood. However, the existing re-
search has shown these patients have an average
intelligence quotient (IQ), especially if one considers
their verbal IQ but not their performance IQ.
It is widely accepted that OCD patients have a poorer
performance in several neuropsychological dimensions
compared to healthy controls, but the corresponding
findings are heterogeneous, a sign that these patients are
clinically diverse. Of the most significant neuropsycho-
logical findings observed to be compromised among
OCD patients, we would like to highlight: attention, ex-
ecutive function, memory, visuospatial ablilities, process-
ing speed and working memory and subdomains, as
sustained attention, planning, response inhibition, set
shifting/cognitive flexibility, verbal memory, non-verbal
memory and spatial working memory [22]. There is a
long debate concerning the reasons for these differences,
and the type and severity of symptoms (assessed by the
total Y-BOCS score) have been mentioned as possible
explanations. In the last decades, however, despite the
publication of different meta-analyses [30], no definite
conclusion has been reached.
Poor insight may result from cognitive deficits and
neuropsychological factors [31]: OCD patients with poor
insight exhibited poorer speech learning and memory
[32], fared worse in the trail-making test (TMT) and the
Auditory-Verbal Learning Test (AVLT) than the group
with better insight [33] and exhibited more severe
neuropsychological deficits in executive functions [33],
conflict resolution/response inhibition and verbal mem-
ory [28]. Nevertheless, very few studies have directly ex-
amined the specific neuropsychological alterations of
OCD patients with poor insight [34]. Although the
worse performance of patients with poor insight has yet
to be conclusively explained, three reasons were ad-
vanced for their worse performance regarding specific
cognitive deficits: 1) difficulties in the inhibition of the
response-resolution conflict may prevent them from
solving, in an adaptive manner, conflicts between their
belief system and the corrective information they receive
from the outside; 2) memory impairments may prevent
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from adequately updating their belief system; 3) fluency
impairments may render the access to pre-existing
memories more difficult [35].
Understanding the differences between insight groups
in OCD can be very useful in the future. If we find, for
instance, that neuropsychological profiles display signifi-
cant contrasts depending on insight, which can be
quickly evaluated in a routine psychiatric consultation,
this discovery will allow us to determine which OCD pa-
tients merit a more detailed neuropsychological evalu-
ation and to direct cognititive-behavioural therapy and
psycho-education specifically towards the cognitive defi-
cits mentioned in the previous paragraph.
In this study, we hypothesized that OCD patients with
poor insight would have greater impairments in tests of
executive functions, such as the WCST and TMT, com-
pared with both OCD patients with good insight and
healthy control subjects. As for memory tests, which re-
quire the use of a very different neural network, involv-
ing the hippocampus, we hypothesized that OCD
patients with both good and poor insight would be
equally impaired and show greater impairment as com-
pared with the healthy control group.
Methods
Participants
Our sample consisted of 57 OCD patients, of which 34
men (59%) and 23 women (41%). We interviewed pa-
tients from the OCD Clinic/Braga Hospital and from the
out-patient unit of Santa Maria Hospital diagnosed with
OCD, according to DSM-IV TR. Eleven patients
dropped out of the first interview, which led to a total of
110 (53 controls + 57 patients) fully evaluated partici-
pants. All patients had ages between 18 and 65 and gave
their informed consent. Those with schizophrenia or
other psychotic disorders, bipolar disorders, mental re-
tardation, substance dependence, degenerative condi-
tions or epilepsy were excluded from the study.
Controls
The control group comprised the 53 blood donors from
the Portuguese Blood Institute who best matched the
clinical sample. From the total control participants, the
outliers were removed and the remaining participants
were included. Note that there were no significant differ-
ences between the OCD group and the control group
(see Table 3), except for the variable “education years”,
which, for this reason, was later controlled using
ANCOVA. All controls were free from any psychiatric
or other medical diseases/conditions.
Measurements
All participants gave their informed consent and were
asked to complete a two-phase interview. First, they
were interviewed by a psychiatrist (the coordinator of
this work). Afterwards, a neuropsychological evaluation
was conducted by two trained neuropsychologists, who
prepared together the agreed protocol and performed
blind interviews (not knowing previously to which study
group the interviewee belonged).
We conducted a semi-structured clinical interview in-
cluding demographic data (age, birth date), data on
medication (to determine whether participats regularly
consumed psychotropic drugs, i.e. drugs belonging to
the following pharmacologic groups: antidepressants,
benzodiazepines, antipsychotics, mood stabilizers or am-
phetamines), years of education, Yale–Brown Obsessive-
Compulsive Scale scores [36, 37] and the Mini Inter-
national Neuropsychiatric Interview (MINI) [38]. MINI
is a short-structured interview that assesses the criteria
of the Diagnostic and Statistical Manual of Mental
Disorders (4th ed.). MINI is considered a valid and time-
efficient alternative to SCID-P (structured clinical inter-
view for DSM-IV) and CIDI (composite international
diagnostic interview), with kappa coefficients between
0.76 and 0.93 [38].
Insight was assessed using BABS. This scale is widely
used because it allows for the comparison of different
studies. Since it can also be used in a categorical manner
[39], we established a cut-off point to distinguish poor
insight (BABS score ≥ 12) from good insight (BABS
score < 12). This allowed us to divide patients into four
different categories, according to their total score: excel-
lent (0–3), good (4–7), fair (8–12) and poor (13–17, or a
total score of 18 plus a score of 0–3 on the conviction
item). Furthermore, BABS considers a given belief to be
delusional when the total score is 18 plus a score of 4 on
the conviction item. In our study, poor insight refers to
a total score > 12, while good insight corresponds to the
other three categories put together (excellent, good, fair).
This option agrees with the existing research on insight
measured with BABS [40–44] and with our own experi-
ence using this scale to evaluate insight in OCD patients.
The English version of BABS was translated into Por-
tuguese by a group of professional translators. The
translation followed the standardized back-translation
procedure to guarantee the semantic equivalence to the
original [39]. This entailed two translations: one from
the original version into Portuguese and another back
into English. The second one was compared with the
original to check for discrepancies and to reach a final
consensus, which was then considered for the final Por-
tuguese text. Each step of the process was carried out by
a different translator. A confirmatory factor analysis was
conducted to validate the one-factor structure of BABS
using AMOS software (see Appendix I).
Neuropsychological evaluation: Besides the clinical
evaluation, all participants were assessed with a battery
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of neuropsychological tests: California Verbal Learning
Test (CVLT) [45, 46], trail-making-test (TMT) [47],
Rey’s complex figure test [48–50], Toulouse–Piéron test
(TBTP) [51], Wisconsin Card Sorting Test (WCST) [52].
All subjects were fluent in Portuguese and tested indi-
vidually in a quiet testing room. The tests were mostly
administered in the same sequence. The testing session
for clinical subjects took approximately 120min. In
order to better detail the metris used, please see Table 1
with each test name as respective variables.
Statistical analysis
All statistical analyses used the Statistical Package for
the Social Sciences (SPSS) for Windows software, ver-
sion 22.0, and the significance level was set at α = 0.05,
i.e. statistical significance is achieved if p < 0.05. The
demographic and clinical characteristics of the three
groups were compared using the Chi-Square and
ANOVA tests. The categorical variables were described
as absolute values (n), and the normal distribution was
assessed by the Kolmogorov–Smirnov test. An extensive
comparison between the good-insight, poor-insight and
control groups was conducted based on CVLT, TBTP,
TMT, Rey’s figure test and WCST, using the ANOVA
test to compare the mean scores between groups. Note
that the level of education is a proxy measure for the
intelligence level and that the statistical analysis of the
education factor in the three groups proved statistically
significant (p = 0.009). Since education level influences
the results of the neuropsychological tests, an ANCOVA
controlling for this factor was used (see Tables 3 and 4).
In order to control for the false discovery rate (FDR),
we conducted a correction for multiple comparisons ac-
cording to Benjamini and Hochberg [53]. By adjusting
the computed p-values based on the FDR, we found that
all previously computed p-values were statistically sig-
nificant if lower than 0.029, i.e., the last rejected hypoth-
esis was the variable “FRey points (late recall)” (see
Table 3). Therefore, all other hypotheses with p-values
lower than 0.05 but higher than 0.029 were not rejected,
according to the aforementioned criterion.
The effect size was assessed with the Excel software,
version 16.30, using the Cohen’s D statistic associated
with the t-test for the comparison of means, the Cohen’s
F statistic associated with ANOVA tests and the Cohen’s
W statistic associated with the Chi-Squared independ-
ence tests.
Results
The key results of this study can be divided into two
parts: the first one comprises the results relating to the
executive functions, summarized in Table 3, and the sec-
ond part comprises those relating to memory functions
(subserved by the hippocampus/temporal lobes), shown
in Table 4. All results are based on the evaluation of 110
participants, divided into the control group (n = 53), the
good-insight group (n = 37) and the poor-insight group
(n = 20), please see Table 2.
As shown in Table 2, the total number of patients
(good-insight + poor-insight) is 57, which is higher than
that of the control group [53]. With a false discovery
rate of 0.029, the three groups did not differ significantly
with regard to age, sex, Y-BOCS total score and compul-
sion and obsession scores. The p value for sex, 0.055, al-
though close to the cut-off point (0.029), does not allow
us to consider this variable as a relevant factor differenti-
ating the three samples.
With p = 0.009, education (years) has proved a signifi-
cant factor, and was therefore controlled afterwards with
an ANCOVA (see Tables 3 and 4).
In what concerns the effects of pharmacological treat-
ment on test performance, the consumption of the
assessed pharmacological groups (antidepressants, ben-
zodiazepines, antipsychotics, mood stabilizers, amphet-
amines) was identified only in the OCD group, with 32
psychotropic users in the good-insight subgroup and 16
in the poor-insight subgroup, corresponding to p ≤
0.001. Therefore, the differences between the three
groups are significant, as the use of psychotropic drugs
was absent in the control group (0.0%) compared to
both OCD groups (good and poor insight). The use of
psychotropic drugs may affect the results of the neuro-
psychological tests. However, both OCD groups were
found to use these drugs in similar percentages (86.5%
vs 80%), which means that this variable cannot account
for the neuropsychological results found.
Comorbidity was assessed using the MINI (based on
DSM-IV-TR), as indicated in the Measurements section.
Moreover, various disorders constituted exclusion cri-
teria, including schizophrenia and bipolar affective dis-
order. Among those that were not excluded, three were
present in the sample, namely mild depression, agora-
phobia and schizoid personality disorder. Considering
that the cut-off point established according to FDR was
0.029, two disorders did not exhibit significant differ-
ences in the two groups and were therefore excluded:
agoraphobia (p = 0.580) and schizoid personality (p =
0.103). Mild depression (p = 0.029) was significantly
more prevalent in the poor-insight group.
Table 3 shows the results of the tests on executive
functions and attention. After the correction for multiple
comparisons mentioned above, only the results with very
low p remained: the “time” criterion of the TMT, which
was more significant in TMT-B (time and errors), and
the WCST’s different evaluation criteria. These results
are relevant due to the magnitude of the differences
found. See, for example, the “errors” variable in WCST:
the errors of patients with poor insight are considerably
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Table 1 Description, for each test, of the executive functions involved and the respective metrics [26]
Test name/measure definition Description
Toulouse-Pierron test (TBTP) It allows to evaluate the selective and sustained attention, as well as the processing speed, providing two main
indices: work yield (RT) and dispersion index (ID).
TBTP-ID (dispersion index) Allows us to understand if the result obtained on the work efficiency was influenced by a response pattern of
impulsivity or innatention. This index is the percentage of errors and omissions divided by the number of hits
obtained by the subject during the test and can be calculated by: DI = E + OHx 100.
TBTP-RT (work-efficiency) Measure of both the attentional and perceptual abilities of the subject. It is related to the total score of hits (H),
errors (E) and omissions (O) and it is calculated by: WE=H− (E + O). It is a measure of the subject’s work quality.
Trail-making test (A/B) Attention and processing speed. TMT B also assess task switching.
TMT A (time) Time used, in seconds, to perform the test.
Trails A is just a psychomotor speed control for Trails B. In trails A you do not switch between numbers and letters,
but just move from number to number connecting them through out the test.
TMT A (errors) Errors made in carrying out the test.
TMT B (time) Time used, in seconds, to perform the test.
TMT-B measures task switching (the participant has to switch from numbers to letters as he/she does the task).
TMT B (errors) Mistakes made in carrying out the test.
Wisconsin Card Sorting Test
(WCST)
This test aims to assess abstract reasoning and the individual’s ability to generate problem-solving strategies in re-
sponse to changing stimulation conditions. In general, your objective is to verify the individual’s performance in
tasks that demand executive functions
WCST errors Total number of errors.
WCST perseverance When the subject persists in responding to a characteristic of the stimulus that is not correct, the response is
considered a perseverance for that criterion and is scored as perseverative. The subject can persevere for the color,
shape or number. Answers that meet the established perseverance criterion are considered perseverative,
regardless of whether they are correct or incorrect. Responses that do not meet the perseverance criterion are
“non-perseverative”.
WCST no perseverance errors Corresponds to the answers that, being wrong, do not follow the preservation criterion by color, shape or number.
WCST perseverance errors If the subject is making a category (eg, relating the bottom card to the top card) following the color criteria and
you make a mistake (for example, you forget the category that was following—the color—and change to
another—e.g. the shape), this error is counted as an error of set maintenance. If, on the other hand, the 10 trials
with the same category are finished, the computer will change to another category. If the subject continues with
the previous category, he will commit a perseverative error.
Rey-Osterrieth Complex Figure
Test (FRey)
This test requires executive functions, in particular, organizational and planning skills [26]. The assessment of these
skills implies an analysis of the subject’s performance, in terms of how he performs the reproduction of the figure
and in terms of the strategies he uses.
FRey points (copy) “FCR-Copy” index obtained through the application of the Osterrieth quotation system and proposed in the
respective test manual (Rey, 1959/2002). This system consists of the evaluation of the 18 elements of the figure
according to two criteria: the position of the element and the reproduction accuracy. The points awarded vary
between 0 and 2 depending on the placement and accuracy of each element, with a maximum score of 36 points.
2 points are assigned for each correct and well positioned unit, 1 point for each correct but poorly positioned unit
or which, although deformed or incomplete, is recognizable but is well positioned, and 0.5 points are attributed to
the unit that is found misplaced and that is deformed or incomplete but recognizable. Finally, the unit that is
unrecognizable or missing is quoted with 0 points.
FRey time (copy) Time needed to make the copy.
FRey points (recall) After a short break that should not exceed three minutes, the subject is invited to draw, on a second sheet, one
second trial consisting of the reproduction of memory of the copied geometric figure. There is no time limit for
playback; it’s the subject himself who will indicate when he has finished.
FRey time (recall) Time needed to make second trial of the reproduction of Rey’s figure.
California Verbal Learning Test
(CVLT)
This test evaluates episodic verbal learning and memory
CVLT A1 Free evocation of Monday’s list. Measures the capacity of information / stimulus coding.
CVLT A5 Free evocation of Monday’s list. Measures the performance of the information encoding after the 4 repetition
sequences.
CVLT A1-A5 Free evocation of Monday’s list. Measures the ability to learn through repetition throughout the test.
CVLT B Free evocation of Tuesday’s list. Objective interference after Monday’s list.
Manarte et al. BMC Psychiatry          (2021) 21:216 Page 5 of 11
higher than those of the other two groups. This fact,
along with the increase in the TMT’s “time” criterion, is
crucial for the debate on the neuropsychological profile
of poor-insight patients, discussed in detail in the next
section. For the ANCOVA tests presented in Table 3,
the control group and the poor insight OCD group ex-
hibited statistically significant differences in TMT A
(time) and TMT B (time), in total WCST errors, WCST
perseverance and in the WCST perseverance errors. The
control group and the good insight OCD group showed
statistically significant differences in the TBTP-RT
(work-efficiency), TMT A (time) and TMT B (time).
The good insight OCD group and the poor insight OCD
group exhibited statistically significant differences in
TBTP-RT (work-efficiency), total WCST errors, WCST
perseverance and WCST perseverance errors.
Table 4 shows the variables used for assessing mem-
ory, i.e. the Rey’s figure and CVLT results controlled for
education years. The differences concerning the Rey’s
figure test (copy and 5-min recall) were the most signifi-
cant. However, since the analysis was based on a mul-
tiple comparison, we resorted to the correction
prescribed by Benjamini and Hochberg, as mentioned
earlier. Following the correction, only the subscores with
p ≤ 0.029 remained, i.e. FRey time (immediate recall),
FRey time (late recall) and FRey points (late recall),
which concern visual memory. None of the CVLT sub-
scores were significant. For the ANCOVA tests pre-
sented in Table 4, the control group and the poor
insight OCD exhibited statistically significant differences
in FRey time (copy) and in FRey time (recall). The con-
trol group and the good insight OCD group showed sta-
tistically significant differences in the FRey time (copy)
and FRey points (recall). The good insight and the poor
insight OCD group exhibited statistically significant dif-
ferences in FRey time (copy), FRey points (recall) and in
FRey time (recall).
Discussion
The main objective of this study was to determine
whether there are relevant neuropsychological differ-
ences between good-insight and poor-insight OCD pa-
tients. It is already known that OCD patients have
various neuropsychological deficits. They were found to
have worse performances in many different studies [22],
particularly concerning sustained attention, planning, re-
sponse inhibition, set shifting, cognitive flexibility, verbal
and non-verbal memory, visuospatial abilities, processing
speed, working memory and special working memory.







Chi-Square/ F-test p Cohen’s
D/F/W
n 53 37 (65%) 20 (35%)
Sex
male 23 19 15 5.814 0.055 W = 0.23
female 30 18 5
Age (years) 33.0 ± 11.8 31.1 ± 11.7 33.1 ± 14.6 0.242 0.785 F = 0.07
Education (years) 14.2 ± 3.2 11.9 ± 2.6 13.2 ± 5.0 4.981 0.009 F = 0.31
Mild depression
yes 1 (1.8%) 5 (13.5%) 4 (20%) 7.084 0.029 W = 0.25
no 52 32 16
Agoraphobia
yes 2 (3.7%) 2 (5.4%) 0 (0%) 1.088 0.580
no 51 35 20 W = 0.10
Schizoid personality
yes 0 0 1 (5.0%) 4.541 0.103 W = 0.20
no 53 37 19
Y-BOCS total score – 25.4 ± 13.3 23.7 ± 11.2 0.227 0.636 D = 0.13
Y-BOCS obsession – 12.8 ± 6.7 12.4 ± 5.4 0.042 0.839 D = 0.06
Y-BOCS compulsion – 12.7 ± 6.8 11.2 ± 6.5 0.576 0.451 D = 0.22
Psychotropics
yes 0 (0.0%) 32 (86.5%) 16 (80.0%) 79.422 ≤0.001 W = 0.85
no 53 5 2
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We hypothesized that OCD patients with poor insight
would have a worse performance on executive function
tests (e.g. WCST and TMT) compared with OCD pa-
tients with good insight. The comparison between differ-
ent neuropsychological studies is very difficult, since the
test batteries are not the same and other study design
characteristics also differ significantly, like the total
number of patients or the methods used to collect the
sample (studies using internet questionnaires and auto-
filled tests tend to have larger samples).
As regards sustained attention, accuracy and fatigue
resistance (TBTP work-efficiency (RT) score, see Table
3), poor-insight OCD patients showed a worse perform-
ance compared to the good-insight group. Given that
poor insight corresponds to a more severe form of OCD,
and that obsessions lead to a decrease in the patients’
reasoning speed, this finding demonstrates the cognitive
difficulties faced by OCD patients, and particularly by
those with poor insight. Previous studies have already
considered the decrease in OCD patients’ task perform-
ance speed, rejecting the hypothesis that such a decrease
is due to intrusive thoughts or meticulousness [54], and
linking it instead to an inadequate precocious inhibition
of competing ideas. However, it should be noted that
these studies have not taken insight into account [54].
Still with regard to task switching and processing speed
(TMT’s time criterion), we found clear differences be-
tween the three groups. Similar differences were also
found in a meta-analysis including 115 studies [22],
showing that OCD patients are indeed slower than
controls.
Since TMT-B is more demanding than TMT-A, the
former presented an even greater difference between the
two groups (p = 0.002 vs p = 0.003), highlighting the cog-
nitive limitations of the poor-insight group, in particular
regarding executive functions and not motor slowing.
Given that poor-insight patients are more severely af-
fected by OCD [55], it is plausible that their TMT per-
formance is worse. Indeed, their difficulty in performing
a task that requires continuous response inhibition and
attentional set shifting is linked to the deficits of patients
who do not respond to, or resist, treatment, namely
poor-insight patients. The cognitive processes involved
in TMT-B are varied, which implies that the cerebral re-
gions involved are also varied [56]. In studies using
voxel-wise lesion symptom mapping (VLSM), which in-
vestigates the neural correlates of a given lesion, it was
concluded that the left rostral anterior cingulate was not
only not exclusive to TMT, but also indicative of poorer
WCST performance. This conclusion is particularly
Table 3 Results of the executive function tests—WCST, TBTP
and TMT—for the control, good-insight and poor-insight







































































































Table 4 ANCOVA results of the memory tests—Rey’s figure test


























28.1 ± 0.9 30.8 ± 1.2 3.602 0.031 0.26
FRey time
(copy)






15.4 ± 1.3 20.2 ± 1.8 4.272 0.016 0.28
FRey time
(recall)
2.3 ± 0.1 2.1 ± 0.2 2.8 ± 0.2 3.653 0.029 0.26
CVLT A1 5.7 ± 0.2 5.4 ± 0.3 5.1 ± 0.4 0.672 0.513 0.11
CVLT A5 11.7 ±
0.4





42.0 ± 1.7 44.5 ± 2.3 3.292 0.041 0.25
CVLT B 5.6 ± 0.3 5.1 ± 0.3 6.1 ± 0.4 1.646 0.198 0.18
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important in the present context, since the patients with
poor insight we have analysed also fared worse in WCST
(see Table 3). In sum, the regions involved in poor
TMT-B performance were all located on the left side.
Nevertheless, the conclusions to be drawn from TMT
must take into account that the increase in the execution
time is not linked to a specific pathology, as it was also
recorded for schizophrenia, for example [57].
In the literature published in the last 10 years on the
executive functions of OCD patients, which does not
consider insight, researchers agree that the WCST is one
of the tests in which OCD patients fare worst [58]. In
our sample, the most common errors in the poor-insight
group concerned perseverance (“perseverance errors”—
WCST) and the patients’ difficulty in adapting their de-
cisions to the results obtained during the test. Cognitive
flexibility and set-shifting were clearly compromised
among poor-insight patients (wcst total errors, wsct per-
severance and perseverance errors) when compared to
the two other groups (see Table 3), what is specifically
due to impairments in cognitive flexibility but not to
poor learning. Given the cognitive rigidity for which ob-
sessive patients are known, this explanation is plausible
and allows us to account for their insight from a neuro-
anatomical perspective, involving the pre-frontal and
dorso-lateral cortices. From an anatomical perspective,
these differences are in accordance with the neuroana-
tomical basis of obsessions and compulsions (orbito-
frontal cortex, anterior cingulate cortex and caudate nu-
cleus) proposed by many authors [4, 59–61]. Another
study, with a smaller sample (14 patients), crossed the
WCST results with the observation of the regional blood
flow and concluded that the perseverance errors were
related with flow changes in the right thalamus [62].
However, this study did not focus specifically on insight.
Although the neuropsychological characteristics of
OCD have been regarded as a phenotypic marker [63],
most results are inconsistent [58]. An important study
comprising 150 OCD patients found significant changes
in their WCST results when compared with those of the
control group [27]. It was proposed that the increased
checking behaviour, due to an effort to avoid making
mistakes and an inability to spontaneously generate al-
ternative solutions and organizational strategies, or sim-
ply indecision when evaluating and choosing between
alternatives, may explain these findings [58]. Deficits in
the executive functions (e.g. decision-making, response
inhibition and cognitive flexibility) may be associated
with insensitivity to the future consequences of patients’
choices and to defective planning in daily life [27, 64].
According to the authors who proposed this association,
these differences can be explained by the patients’
organizational strategies. However, the reason for this
has yet to be clarified, and not all studies point in the
same direction [23, 53, 55, 56]. Finally, in a research
completed in 2009, WCST scores were similar in differ-
ent insight groups [33], but not in schizophrenic
patients. This study proposed cognitive flexibility and
set-shifting as “candidate” characteristics to what the
authors call an “endophenotype of early-onset OCD”
[65, 66] based on the WCST and TMT (among other)
scores. In light of Tumkaya et al.’s conclusions and our
own results, OCD patients with poor insight show some
similarities in cognitive dysfunction to patients with
schizophrenia [33].
As for visuospatial constructional abilities and visual
memory (Rey’s complex figure test), these skills (associ-
ated with frontal lobe function [28, 59, 67]) are very im-
portant for daily life and for many different aspects of
cognitive and visual capabilities [68]. The differences ob-
served in the studied groups were statistically significant
(see Table 4) and require a detailed analysis. If, on the
one hand, patients with poor insight scored higher than
those with good insight (which means that their copy
was more accurate), the opposite is true when it comes
to the time spent, measured by the F.Rey time copy and
the F.Rey recall items. It is possible that patients with
poor insight, although having provided better copies,
spent more time drawing them. This result may be seen
as a consequence of the dysfunction and the deficit in
planning and organizational strategies exhibited by OCD
patients [48, 63].
In what concerns verbal memory, the existing results
have always been controversial, and our study is no ex-
ception [22]. While no differences were found on the
CVLT, some links between verbal memory and poor
insight in OCD were recorded [28]. To the best of our
knowledge, no real consensus has been reached as to
what these findings mean [32]. It was also proposed that
verbal memory is not affected by OCD [27, 58, 63, 69].
These studies argue that verbal memory is not compro-
mised, but rather the patients’ “organizational strategies”
[63]. Deckersbach et al. proposed that OCD patients
underutilize organizational strategies rather than lacking
verbal memory per se [70]. The fact that verbal memory
was not significantly different in the good-insight and
poor-insight groups suggests that what differentiates
OCD patients is not memory, which is preserved in this
disease [55], but more complex functions, such as the
executive functions discussed above.
In order to secure the homogeneity of our sample and
avoid biases, several comorbities were excluded from
our study, such as schizophrenia, bipolar affective dis-
order and mental retardation. Of those that were in-
cluded, according to the MINI’s criteria, three were
found in the sample: schizotypal personality disorder,
agoraphobia and mild depression (see Table 2). Only
one case of schizotypy was found, in the poor-insight
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group. This fact, although lacking statistical relevance, is
plausible, given the link between schizotypy and insight
[71]. Indeed, several bibliographic sources point to a cor-
relation between OCD with poor insight, and hence with
worse prognosis, and schizotypal disorders [5]. However,
we have not used a specific scale to measure schizotypy,
which might have yielded different results. Agoraphobia,
a fairly frequent disorder, was also statistically insignifi-
cant, with only four cases in the whole sample—two in
the good-insight group and two in the control group. Al-
though many authors claim that patients with poor
insight display more comorbidities, recent studies have
also failed to identify statistically relevant values of
agoraphobia in OCD groups with good and poor insight
[72], which suggests, for now, that the comorbidity of
OCD with agoraphobia is not a research priority. As for
depression, the percentage of patients suffering from this
condition was higher in the poor-insight group (with
p = 0.029, which coincides with the cut-off value, and a
low effect size (0.25)). In our view, since the absolute
quantity of individuals with depression was less than 5,
any conclusions based on a statistical analysis of these
data would be biased. Therefore, we leave the investiga-
tion of this aspect to future studies with larger
subsamples.
Finally, it is worth mentioning the main limitations of
this research. However, insight assessment changes over
time, limiting the research of this issue. Our study is
cross-sectional, which means we have not taken into ac-
count changes in symptomatology and insight in the
course of time, unlike other authors [73]. This limits the
depth of our analysis. Moreover, although the scale we
have used to measure insight, BABS, enables good com-
parisons with other studies on insight, it is based only
on patients’ pre-existing and explicitly held beliefs [35,
74], which limits its results. As regards the sample size,
although it is similar to that of other studies, future re-
search should aim for larger samples so as to reach
broader conclusions with stronger p values.
Conclusions
The overall direction of our results leads us to conclude
that OCD patients with poor insight have a significantly
worse neuropsychological performance than the good-
insight and control groups. In summary, poor-insight
patients have greater neuropsychological dysfunction
than those with good insight, especially regarding the ex-
ecutive functions. On the contrary, verbal memory does
not seem to differ in the three groups. Moreover, we be-
lieve that a neuropsychological evaluation of poor-
insight patients is crucial for their future and clinical
outcome, particularly if it leads to the development of
targeted neurocognitive therapies.
Future work in this field will require larger sample
sizes, the inclusion of functional imaging examination
and a longitudinal clinical evaluation.
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